Stigma, fear and cost prevent many patients from getting screened for lung cancer. This can prove deadly for the most vulnerable.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Lung cancer screening
Menampilkan semua artikel
The success of anti-smoking campaigns has come with growing stigma around lung cancer. Over one quarter of Australians admit they have less sympathy for lung cancer sufferers.
While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. New screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.
PODCAST: The third part of a series from The Anthill podcast on how personalised medicine may become in the future.
Cancer mortality has dropped in the US, due largely to lower smoking rates, as well as early detection and better treatments. These advances often do not extend to people in developing nations.
Kontributor teratas
-
Senior Lecturer and Ethics Coordinator for the School of Social Sciences Science and Technology, University of Westminster
-
Professor of Clinical Pharmaceutics, University of Central Lancashire
-
Chief of Hematology/Oncology, Medical Director of the Cancer Center, and Eleanor Eustis Farrington Chair in Cancer Research, UMass Chan Medical School
-
Head of Personalised Medicine and Health, University of Leeds
-
Principal Research Fellow in the Centre for Regional Economic and Social Research (CRESR) and Associate Fellow of the Advanced Wellbeing Research Centre (AWRC), Sheffield Hallam University
-
Associate Director of Community Outreach in Thoracic Oncology, University of Miami
-
Postdoctoral Research Fellow, University of Sydney
-
Professor of Sociology & Director, Sydney Centre for Healthy Societies, University of Sydney
-
ARC DECRA Senior Research Fellow, University of Sydney
-
Researcher, Department of Medical Oncology, Royal North Shore Hospital,, University of Sydney
-
Assistant Professor of Pulmonary Sciences and Critical Care, University of Colorado Anschutz Medical Campus
